CVS Deal To Buy Oak Street At $39 Per Share Brings Arbitrage Opportunity, Says StoryTrading's Rabizadeh

Zinger Key Points
  • Oak Street added to its Tuesday's gains after CVS confirmed the takeover deal.
  • With the premarket gain on Wednesday, the stock is still trading at a discount to the deal value.

Healthcare giant CVS Health Corp. CVS announced on Wednesday a definitive agreement to buy primary healthcare provider Oak Street Health Inc. OSH.

What Happened: CVS said it would buy Oak Street in an all-cash deal valued at $39 per share, representing an enterprise value of about $10.6 billion. This per-share price represents a 15.8% premium over the target company’s closing price of $33.68 on Tuesday.

See Also: Best Healthcare Stocks

Incidentally, reacting to a Wall Street report of a potential deal, Oak Street shares ended Tuesday’s session 29.74% higher. At one point in the session, the stock hit an intraday high of $34.63.

The purchase price is about 50.2% higher than Oak Street’s closing price of $25.96 on Monday — the session before the rumor broke out.

“Combining Oak Street Health’s platform with CVS Health’s unmatched reach will create the premier value-based primary care solution,” said CVS Health President and CEO Karen Lynch.

The deal is expected to close in 2023. By 2026, CVS expects Oak Street will likely contribute $2 billion in adjusted EBITDA and synergy potential of $500 million over time.

Arbitrage Opportunity: StoryTrading founder Ben Rabizadeh said there is an arbitrage opportunity available, given Oak Street is trading under $35.

He also flagged Cano Health Inc. CANO, Talkspace Inc. TALK and DarioHealth Inc. DRIO as sympathy play.

According to Benzinga Pro data:

Market News and Data brought to you by Benzinga APIs
Posted In: M&ANewsPenny StocksHealth CareSmall CapTop StoriesTrading IdeasGeneralall-cash dealarbitrageBen RabizadehStoryTrading
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!